Vasa DenticityNSE:DENTALKART +1.04%37 ROE % is 9.93% as of Sep. 2025, which is 76% below its 10-year median of 40.55. GuruFocus rates NSE:DENTALKART with a GF Score™ of 37/100. The stock has 5 warning signs investors should review. Among 115 Medical Distribution companies, Vasa Denticity ranks better than 73.91% on this metric.
ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Vasa Denticity's annualized net income for the quarter that ended in Sep. 2025 was ₹150 Mil. Vasa Denticity's average Total Stockholders Equity over the quarter that ended in Sep. 2025 was ₹1,515 Mil. Therefore, Vasa Denticity's annualized ROE % for the quarter that ended in Sep. 2025 was 9.93%.
The historical rank and industry rank for Vasa Denticity's ROE % or its related term are showing as below:
NSE:DENTALKART'
s ROE % Range Over the Past 10 Years
Min: 12.4 Med: 40.55 Max: 163.8
Current: 12.4
During the past 5 years, Vasa Denticity's highest ROE % was 163.80%. The lowest was 12.40%. And the median was 40.55%.
NSE:DENTALKART's ROE % is ranked better than 73.91% of 115
companies
in the Medical Distribution industry
Industry Median: 7.1
vs NSE:DENTALKART: 12.40
Vasa Denticity (NSE:DENTALKART) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is two times the semi-annual (Sep. 2025) net income data. The Revenue data used here is two times the semi-annual (Sep. 2025) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
Vasa Denticity ROE % Related Terms
Vasa Denticity ROE % Historical Data
* Premium members only.
The historical data trend for Vasa Denticity's ROE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Vasa Denticity's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vasa Denticity ROE % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Vasa Denticity's ROE % distribution charts can be found below:
* The bar in red indicates where Vasa Denticity's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Sep. 2025) net income data.
ROE % is displayed in the 30-year financial page.
Vasa Denticity (NSE:DENTALKART) has a ROE % of 9.93% as of Sep. 2025. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Vasa Denticity and its competitors. This is 76% below median its historical median of 40.55. Over the past decade, Vasa Denticity's ROE % has ranged from 12.40 to 163.80. According to the industry distribution chart, Vasa Denticity ranks #30 out of 115 companies in the Medical Distribution industry, placing it in the top 26.1%.
Is Vasa Denticity's ROE % too high?
Vasa Denticity's current ROE % of 9.93% is 76% below median its 10-year median of 40.55. Over the past 10 years, this metric has ranged from a low of 12.40 to a high of 163.80. The Medical Distribution industry median ROE % is 7.10. Vasa Denticity's value of 9.93% is 39.9% above this industry median. Based on the distribution chart, Vasa Denticity ranks #30 out of 115 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Vasa Denticity has a GF Score™ of 37/100, reflecting its overall financial health beyond just this single metric.
How does Vasa Denticity's ROE % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Vasa Denticity ranks #30 out of 115 companies for ROE %. This puts Vasa Denticity in the upper half of its industry. The industry median ROE % is 7.10. Vasa Denticity's value of 9.93% is 39.9% above this benchmark. Historically, Vasa Denticity's own ROE % has ranged from 12.40 to 163.80 over the past decade. While the company's 10-year median is 40.55 vs. the industry median of 7.10, Vasa Denticity has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Medical Distribution company?
The median ROE % among Medical Distribution companies is 7.10, based on 115 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vasa Denticity's current ROE % of 9.93% is 39.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Vasa Denticity and its competitors. For the Medical Distribution industry, the median ROE % is 7.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vasa Denticity's current ROE % is 9.93%, which is 76% below median its own 10-year median of 40.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vasa Denticity stock overvalued right now?
Vasa Denticity (NSE:DENTALKART) has a current ROE % of 9.93%. The current ROE % is 9.93%, which is 76% below median its 10-year median of 40.55 and 39.9% above the Medical Distribution industry median of 7.10. Vasa Denticity's overall GF Score™ is 37/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Vasa Denticity (NSE:DENTALKART), the current ROE % is 9.93% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Vasa Denticity Ltd is engaged in marketing and distributing a comprehensive portfolio of dental products, including consumables, instruments, equipment, and accessories for diagnosing, treating, and preventing dental conditions, as well as improving the aesthetics of the human smile through the online portal Dentalkart.com. The company's products include instruments, disinfectant tools, sterilizing equipment, impression materials, temporary materials for tooth filling, and others.
37GF Score
Get the complete analysis for NSE:DENTALKART
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:DENTALKART has been successfully added to your 